Transformation in Trials
A podcast about the transformations in clinical trial. As life science companies are pressured to deliver novel drugs faster, data, processes, applications, roles and change itself is changing. We speak to people in the industry that experience these transformations up close and make sense of how the pressure can become a catalyst for transformation.
- Update frequency
- every 10 days
- Average duration
- 38 minutes
- Episodes
- 84
- Years Active
- 2022 - 2025
Exploring the Impact of Open Source Software on the Pharmaceutical Industry with Katja Glass
Prepare to uncover the transformative potential of open source software in the pharmaceutical industry! Our distinguished guest, Katja Glass, an influential open source ambassador, join…
The Ethical and Legal Challenges in Unapproved Drug Access: A Talk with Patti Zettler
Imagine being given a shot at a cure before it's even approved. That's the fascinating world of expanded access programs for unapproved investigational interventions that we're explorin…
Bridging the Gender Gap in Medical Research: The Potential of Wearable Technology
Imagine you're on an eight-year journey trying to diagnose an autoimmune disease. Suzaan Sauerman, our insightful guest today, faced this exact challenge. Sauerman, a visionary in femal…
The Hidden Factors Behind Executive Retention in Life Sciences
Let's face it, executive turnover in the life sciences industry is a conundrum. Companies are offering competitive compensation, fostering positive work cultures, and providing opportun…
Ravi Samavedam: On demand clean rooms for clinical trial supply
This week we speak to Ravi Samavedam, Chief Innovation Officer for Azzur Group, about how on demand clean rooms can transform the business model for biotechs.
We start out by exploring …
Leif Kuse: Nudging the industry towards innovation with group purchasing for biotechs
This week we speak to Leif Kuse, who is Lead Trailblazer of Drug Development Outsourcing Disruption and CEO PHARALL.
We speak about group purchasing for biotechs in clinical trials. We s…
Tirrell Payton: Transforming the mindset in Life Sciences from Punitive to Innovative
This week we speak to Tirrell Payton, Managing Partner at Nooma Group Consulting, about mindset in life sciences.
We speak about how there is a disconnect between the level of risk will…
Philip Russmeyer: Revolutionising clinical trials with true data anonymization
This week we speak to Philip Russmeyer, Founder & CEO of Fitfile, about the promises that true data anonymization holds for transforming clinical trials.
We dive into the differences be…
Sam Ewing: Virtual Wards & Digital Endpoints
This week we host Sam Ewing, who is the Global Head of Pharma Partnerships at Doccla. We speak about endpoint development in general - and digital endpoint development in particular.
We…
Christian Born Djurhuus: Rethinking the waterfall approach of drug development
This week we host Christian Born Djurhuus, who is a physician by training, a self-proclaimed geek and has had an impressive career in life sciences in the intersections between drug dev…
Simon Taylor: We need to deal with technological debt at clinical sites
This week we speak to Simon Taylor, Head of European Solutions Consulting at Florence Healthcare. We focus on site oriented technology transformation.
We speak about the current challen…
Ole Henriksen: How health technology assessments transformed clinical development
This week we speak to Ole Henriksen, Associated Partner of Nordic Healthcare Group and pharmaceutical market access expert. We speak about how health technology assessments (HTA) has im…
Kimberly Tableman: Does true transformation in trials start with the clinical protocol?
This week we are hosting Kimberly Tableman, Founder and CEO of ESPERO Health, and speak about how clinical trial protocols are being re-imagined in our industry. We dive into what a pro…
André Chagwedera: Patients should decide which research is funded
This week we have André Chagwedera in the studio, the Founder and CEO of Fleming Protocol. We focus on health data, and what it would mean for patients to own their data.
One of the con…
Raj Indupuri: Data is the currency of the life sciences industry
We speak to Raj Indupuri, the co-founder & CEO of eClinical Solutions, about why data plays such a key role in our industry. And dispute this being true for as long as we have had clini…
Lars Rosendal: Leadership as the differentiating factor when drug development is uncertain
Today we speak with Lars Rosendal, the VP of Global Clinical Operations at LEO Pharma. We speak about how clinical development is an innovation game - and how both governments and patie…
Rebecca Godfrey: How does a specialist transform into a leader?
In this episode we speak to Rebecca Godfrey, the author of The Leadership Vaccine, about transforming specialists into leaders. In The Leadership Vaccine we follow a story of how a comp…
Sophia Zilber: Getting to quality research from patient registries
Today is World Rare Disease day. It is only fitting that we speak to Sophia Zilber who is a statistical programmer, but also Board Member & Director of Patient Registries at the Cure M…
Johan Lauritsen: There needs to be a simple apply button to participate in a clinical trial
We speak to Johan Lauritsen, CEO & Founder of Probe, about how clinical trials can be an alternative to treatment.
Johan himself tried to enrol in a clinical trial for his rare chronic …
Maya Zlatanova: Setting the clinical trial up for success by listening to the healthcare ecosystem
We speak to Maya Zlatanova, the CEO and Founder of Trialhub and FindMeCure about trial strategy for clinical trials. We speak about the amount of information necessary to digest in orde…